FBXO10 and neoplasm: Diverging from canonical F-box protein functions in proteasomal substrate degradation, FBXO10 exhibits a non-degradative oncogenic mechanism in HCC by stabilizing FRMPD1 through K63-linked polyubiquitination—a functional dichotomy contrasting with its tumor-suppressive role in lymphoid malignancies [14].